Lori E. Crosby

Lori E. Crosby

Auto-generated profile, based on publicly available information

Lori E. Crosby

Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2018 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Sherif M. BadawySherif M. Badawy
Sherif M. Badawy
RCRobert M Cronin
Robert M Cronin
JHJane S Hankins
Jane S Hankins
LCLori Crosby
Lori Crosby
MDMichael DeBaun
Michael DeBaun
NSNirmish Shah
Nirmish Shah
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Sickle cell disease (SCD) is an inherited blood disorder that affects over 100,000 Americans. SCD-related complications lead to significant morbidity and early mortality. There is a growing evidence to support the feasibility, acceptability and efficacy of self-management e-health interventions in chronic diseases; however, the evidence is unclear in SCD. Objective: We systematically evaluated the most recent evidence of the literature to: (1) review the different types of technological tools used for self-management in SCD, (2) to discover and describe what self-management activities these tools were used for, and (3) to assess the efficacy of these technologies in self-management. Methods: This review covered literature published between 1995 and 2016 with no language limits. Searches included PubMed MEDLINE, Embase, CINAHL, PsycINFO and other sources. We followed the guidelines for the preferred reporting items for systematic reviews and meta-analyses (PRISMA). Two independent reviewers screened titles and abstracts, assessed full-text articles, and extracted data from articles that met inclusion criteria. Eligible studies were original research articles that included texting, mobile phone–based apps or other e-health interventions designed to improve self-management in pediatric and adult patients with SCD. Results: Of 1680 citations, only 16 articles met all predefined criteria with a total of 747 study participants. Interventions included text-messaging (4/16, 25%), native mobile apps (3/16, 19%), web-based applications (5/16, 31%), mobile directly observed therapy (2/16, 13%), Internet-delivered cognitive behavioral therapy (2/16, 13%), electronic pill bottle (1/16, 6%), or interactive gamification (2/16, 13%). Interventions targeted monitoring and/or improvement of medication adherence (5/16, 31%); self-management, pain and symptoms reporting (7/16, 44%); stress, coping, sleep and daily activities reporting (4/16, 25%); cognitive training for memory (1/16, 6%); SCD and reproductive health knowledge (5/16, 31%); cognitive behavioral therapy (2/16, 13%) and guided relaxation interventions (1/16, 6%). Most studies (11/16, 69%) included older children or adolescents (mean or median age 10-17 years old), 5 included young adults (≥18 years old) (5/16, 31%), and only 2 allowed parents to participate (2/16, 13%). Sample size ranged from 11 to 236, with a median of 21 per study; < 20 in 6 (38%), ≥ 20 to < 50 in 6 (38%), and >50 participants in 4 studies (25%). Study design was pre-post pilot or feasibility trials in 7 (44%), randomized controlled trials (RCT) in 5 (31%), single-arm observational studies in 2 (13%), quasi-experimental in 1 (6%), and retrospective in 1 study (6%). All studies were performed in the United States. The duration of the intervention ranged from 3 days to 12 months as follows: ≤ 3 months in 7 (44%), > 3 and ≤ 6 months in 5 (31%), or > 6 and up to 12 months in 2 studies (13%). Retention rates were < 80% in 4 (25%), ≥ 80% and < 100% in 6 (38%), 100% in 1 (6%), and not reported in 5 studies (31%). Only 6 studies (38%) were informed by a clear theoretical framework for their intervention effects, including Health Belief Model; Theory-based Game Design; Gate Control Theory; Transactional Stress Model; Coping Theoretical Model; Theory of Reasoned Action; and Kolb Experiential Learning Theory. Most reported improvement in self-management related outcomes (15/16, 94%) as well as high satisfaction and acceptability of different study interventions (10/16, 63%). Conclusions: Our systematic review identified a number of e-health interventions measuring a variety of outcomes, which showed improvement in multiple components of self-management in SCD. Despite the promising feasibility and acceptability of e-health interventions in improving self-management in SCD, the evidence overall is modest. Future e-health intervention studies are needed to evaluate their efficacy, effectiveness, and cost-effectiveness in promoting self-management in patients with SCD using rigorous methods and theoretical frameworks with clearly defined clinical outcomes. Clinical Trial: N/A

30 August 2016 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
LCLori E. Crosby
Lori E. Crosby
RWRussell E. Ware
Russell E. Ware
AGAlana Goldstein
Alana Goldstein
AWAshley Walton
Ashley Walton
NJNaomi E. Joffe
Naomi E. Joffe
MBMaria T. Britto
Maria T. Britto

1 August 2009 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
LCLori E. PsyD Crosby
Lori E. PsyD Crosby
AMAvani Modi
Avani Modi
KLKathleen L. Lemanek
Kathleen L. Lemanek
SGShanna M. Ma Guilfoyle
Shanna M. Ma Guilfoyle
KKKaren A. Kalinyak
Karen A. Kalinyak
MMMonica J. Mitchell
Monica J. Mitchell
Purpose The purpose of this study was to examine perceived barriers to clinic attendance and strategies to overcome these barriers for adolescents with sickle cell disease. Materials and Methods This was a 2-phased study, which used focus groups (n=13) and individual semistructured interviews (n=32) with adolescent patients (aged 13 to 21 y) from 3 pediatric sickle cell clinics in the Midwest. Results Adolescents identified competing activities, health status, patient-provider relationships, adverse clinic experiences, and forgetting as barriers to clinic attendance. Calendars/reminders and parent reminders were the most commonly reported strategies to facilitate clinic attendance. Adolescents also reported the need for flexible scheduling and improved patient-provider communication. Discussion Adolescents with sickle cell disease and their families may benefit from ongoing education about the importance of attending routine clinic visits. Adherence to clinic appointments for adolescents may be enhanced by developing interventions to decrease forgetting (eg, phone call reminders or text messaging) and increase patient satisfaction with clinic visits. Scheduling appointments to accommodate busy schedules/scheduling conflicts (eg, late clinic hours), providing teen-friendly clinic environments, and using technology may also facilitate attendance.

8 September 2020 in Ethnicity & Health
Verified
Journal Article
Closed access
AHAnna M. Hood
Anna M. Hood
LCLori E. Crosby
Lori E. Crosby
EHEva Hanson
Eva Hanson
LSLisa Shook
Lisa Shook
JLJeffrey D. Lebensburger
Jeffrey D. Lebensburger
ZTZina Trost
Zina Trost
Objectives: Individuals with sickle cell disease (SCD) experience significant health problems that may result in unpredictable pain episodes and frequent healthcare utilization. Disparities in clinical care may contribute to health-related stigma and racial bias for this majority African-American/Black population. There is less known about the influence of health-related stigma and racial bias on the health-related quality of life (HRQOL) of children with SCD. In the present study, we assessed these relationships and identified differences across demographic factors (i.e. age, gender). Design: Data was collected from African American children with SCD aged 8–16 years (57% male, 63% HbSS). Children completed the Childhood Stigma Scale (adapted for SCD), the Child Perceptions of Racism in Children and Youth scale, and the Pediatric Quality of Life Inventory Sickle Cell Disease Module. Caregivers provided demographic information. Results: In the first regression model, health-related stigma (p = .007) predicted HRQOL, but neither age nor gender were significant predictors. In the second regression model, age (p = .03) predicted HRQOL, but neither gender nor racial bias were significant predictors. Of interest, there was a significant interaction between age, gender, and racial bias (p = .02). Specifically, older girls who reported high levels of perceived racial bias had poorer HRQOL. Conclusions: Our study highlights the need for increased awareness about the effects of health-related stigma and racial bias on HRQOL for children with SCD, particularly for older girls who endorse racial bias. Our findings will guide future stigma and bias reduction interventions that may meet the needs of older girls with SCD.

2 April 2015 in Advances in Therapy
Verified
Journal Article
Open access
PDF file
LCLori E. Crosby
Lori E. Crosby
CQCharles T Quinn
Charles T Quinn
KKKaren A. Kalinyak
Karen A. Kalinyak
The lifespan of patients with sickle-cell disease (SCD) continues to increase, and most affected individuals in high-resource countries now live into adulthood. This necessitates a successful transition from pediatric to adult health care. Care for transitioning patients with SCD often falls to primary care providers who may not be fully aware of the many challenges and issues faced by patients and the current management strategies for SCD. In this review, we aim to close the knowledge gap between primary care providers and specialists who treat transitioning patients with SCD. We describe the challenges and issues encountered by these patients, and we propose a biopsychosocial multidisciplinary approach to the management of the identified issues. Examples of this approach, such as transition-focused integrated care models and quality improvement collaboratives, with the potential to improve health outcomes in adulthood are also described.

17 July 2017 in Advances in Therapy
Verified
Journal Article
Closed access
PDF file
HSHeather Strong
Heather Strong
MMMonica J. Mitchell
Monica J. Mitchell
AGAlana Goldstein-Leever
Alana Goldstein-Leever
LSLisa Shook
Lisa Shook
PMPunam Malik
Punam Malik
LCLori E. Crosby
Lori E. Crosby